ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

FIXX Company Profile and Key Details

NASDAQ : FIXX

Homology Medicines, Inc.

$0.93

0.0071+0.77%

At Close 4:00 PM

Not Actively Trading

58.96

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

FIXX Stock Price Chart

Stock Price Today

Homology Medicines, Inc. (FIXX) stock surged +0.77%, trading at $0.93 on NASDAQ, up from the previous close of $0.93. The stock opened at $0.92, fluctuating between $0.90 and $0.97 in the recent session.

Stock Snapshot

0.9276

Prev. Close

0.92

Open

3.02M

Market Cap

3.23M

Number of Shares

0.9

Day Low

0.9725

Day High

-0.026629629629629628

P/E Ratio

63.24%

Free Float in %

-35.1

EPS (TTM)

1.26

Book Value

-1.67

Cash Flow per Share

401.47K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 25, 2024	0.92	0.97	0.90	0.93	401.47K
Mar 22, 2024	0.88	0.94	0.86	0.93	226.01K
Mar 21, 2024	0.88	0.90	0.87	0.89	123.28K
Mar 20, 2024	0.86	0.96	0.86	0.91	569.3K
Mar 19, 2024	0.91	0.94	0.88	0.90	359.1K
Mar 18, 2024	0.91	0.91	0.88	0.90	370.01K
Mar 15, 2024	0.92	0.94	0.92	0.92	150.41K
Mar 14, 2024	0.91	0.96	0.91	0.93	297.29K
Mar 13, 2024	0.88	0.91	0.87	0.91	88.79K
Mar 12, 2024	0.89	0.90	0.88	0.90	162.63K
Mar 11, 2024	0.89	0.91	0.89	0.91	139.01K
Mar 08, 2024	0.89	0.92	0.88	0.89	135K
Mar 07, 2024	0.90	0.92	0.86	0.90	158.4K
Mar 06, 2024	0.88	0.93	0.87	0.91	79.81K
Mar 05, 2024	0.88	0.90	0.88	0.88	131.62K
Mar 04, 2024	0.90	0.90	0.86	0.89	219.17K
Mar 01, 2024	0.93	0.94	0.88	0.89	221.69K
Feb 29, 2024	0.90	0.93	0.88	0.92	364.68K
Feb 28, 2024	0.92	0.94	0.90	0.92	418.84K
Feb 27, 2024	0.89	0.92	0.87	0.92	369.09K

Contact Details

Bedford, MA 01730

United States

Website: https://www.homologymedicines.comContact: 781 301 7277

About Company

Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing for various genetic disorders. The company's various set of AAVHSCs allows company to target, through a single injection, a range of disease-relevant tissues, including the liver, central nervous system, peripheral nervous system, bone marrow, cardiac and skeletal muscle, and eye. Its lead product candidate is HMI-102, which is in Phase 2 pheNIX clinical trial, a gene therapy for the treatment of phenylketonuria (PKU) in adults. The company also develops HMI-103 for the treatment of PKU in pediatric patients; HMI-202 to treat metachromatic leukodystrophy; and HMI-203 for the treatment of mucopolysaccharidosis type II, as well as HMI-104 for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts.

Frequently Asked Questions

What is the current Homology Medicines, Inc. (FIXX) stock price?

Homology Medicines, Inc. (NASDAQ: FIXX) stock price is $0.93 in the last trading session. During the trading session, FIXX stock reached the peak price of $0.97 while $0.90 was the lowest point it dropped to. The percentage change in FIXX stock occurred in the recent session was 0.77% while the dollar amount for the price change in FIXX stock was $0.01.

FIXX's industry and sector of operation?

The NASDAQ listed FIXX is part of Biotechnology industry that operates in the broader Healthcare sector. Homology Medicines, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of FIXX?

Dr. Deborah Kinch Ph.D.
Chief Devel. Officer
Dr. Saswati Chatterjee Ph.D.
Co-Founder & Member of Scientific Advisory Board
Dr. Julie Jordan M.D.
Chief Medical Officer
Mr. Michael Blum M.B.A.
Chief Commercial Officer
Dr. Paul Alloway J.D., Ph.D.
Chief Legal Officer & Sec.
Ms. Theresa McNeely
Chief Communications Officer & Patient Advocate
Ms. Melissa Gelormini
Senior Vice President of HR
Mr. W. Bradford Smith CPA, M.B.A.
Chief Financial Officer, Treasurer & Chief Bus. Officer
Dr. Albert Seymour Ph.D.
Chief Executive Officer, Pres & Director
Cara Mayfield
Director of Corporation Communications

How FIXX did perform over past 52-week?

FIXX's closing price is 3.86% higher than its 52-week low of $0.90 where as its distance from 52-week high of $26.64 is -96.49%.

How many employees does FIXX have?

Number of FIXX employees currently stands at 7.

Link for FIXX official website?

Official Website of FIXX is: https://www.homologymedicines.com

How do I contact FIXX?

FIXX could be contacted at phone 781 301 7277 and can also be accessed through its website. FIXX operates from One Patriots Park, Bedford, MA 01730, United States.

How many shares of FIXX are traded daily?

FIXX stock volume for the day was 401.47K shares. The average number of FIXX shares traded daily for last 3 months was 29.54K.

What is the market cap of FIXX currently?

The market value of FIXX currently stands at $3.02M with its latest stock price at $0.93 and 3.23M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	7
Beta	-0.11
Sales or Revenue	$1.16M
5Y Sales Change%	-0.845%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology